Logo.png
Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022
04. August 2022 08:30 ET | Biofrontera Inc.
WOBURN, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will...
Logo.png
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises
30. Dezember 2021 08:45 ET | Biofrontera Inc.
WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced that through...